REDWOOD CITY, Calif.--(BUSINESS WIRE)--Atreca, Inc., a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, announced today that Dr. Tito A. Serafini, Atreca’s Chief Executive Officer and Co-Founder, will present at the 18th Annual BIO CEO & Investor Conference, taking place at the Waldorf Astoria New York, February 8-9, 2016. Dr. Serafini is scheduled to present on Monday, February 8, at 1:45 p.m. Eastern Time in the Park North Room. During his presentation, Dr. Serafini will provide an overview of Atreca’s platform and programs in cancer immunotherapy, as well as a business update.
